These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 17292871)
1. LDL resistance to oxidation: effects of lipid phenotype, autologous HDL and alanine. Baldi S; Frascerra S; Ferrannini E; Natali A Clin Chim Acta; 2007 Apr; 379(1-2):95-100. PubMed ID: 17292871 [TBL] [Abstract][Full Text] [Related]
2. HDL capacity to inhibit LDL oxidation in well-trained triathletes. Brites F; Zago V; Verona J; Muzzio ML; Wikinski R; Schreier L Life Sci; 2006 May; 78(26):3074-81. PubMed ID: 16488445 [TBL] [Abstract][Full Text] [Related]
3. [High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides]. Posadas-Romero C; Posadas-Sánchez R; Juárez-Rojas JG; Medina-Urrutia A; Jorge-Galarza E; Cardoso-Saldaña G; Caracas-Portilla N; Mendoza-Peŕez E Arch Cardiol Mex; 2008; 78(1):30-9. PubMed ID: 18581711 [TBL] [Abstract][Full Text] [Related]
4. HDL enhances oxidation of LDL in vitro in both men and women. Solakivi T; Jaakkola O; Salomäki A; Peltonen N; Metso S; Lehtimäki T; Jokela H; Nikkari ST Lipids Health Dis; 2005 Oct; 4():25. PubMed ID: 16242018 [TBL] [Abstract][Full Text] [Related]
5. Marrubium vulgare extract inhibits human-LDL oxidation and enhances HDL-mediated cholesterol efflux in THP-1 macrophage. Berrougui H; Isabelle M; Cherki M; Khalil A Life Sci; 2006 Dec; 80(2):105-12. PubMed ID: 17045616 [TBL] [Abstract][Full Text] [Related]
6. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia. Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691 [TBL] [Abstract][Full Text] [Related]
7. Lipid-lowering and LDL-oxidation inhibitory effects of aqueous extract of freshwater clam (Corbicula fluminea)--using tilapia as an animal model. Chen TY; Lin BC; Shiao MS; Pan BS J Food Sci; 2008 Sep; 73(7):H148-54. PubMed ID: 18803709 [TBL] [Abstract][Full Text] [Related]
8. Effect of caffeine on oxidation susceptibility of human plasma low density lipoproteins. Krisko A; Kveder M; Pifat G Clin Chim Acta; 2005 May; 355(1-2):47-53. PubMed ID: 15820477 [TBL] [Abstract][Full Text] [Related]
9. Effect of simvastatin on the oxidation of native and modified lipoproteins. Sobal G; Sinzinger H Biochem Pharmacol; 2005 Oct; 70(8):1185-91. PubMed ID: 16143314 [TBL] [Abstract][Full Text] [Related]
10. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Rizzo M; Berneis K; Hersberger M; Pepe I; Di Fede G; Rini GB; Spinas GA; Carmina E Hum Reprod; 2009 Sep; 24(9):2286-92. PubMed ID: 19454589 [TBL] [Abstract][Full Text] [Related]
11. Effect of 3,4-dihydroxyphenylalanine on Cu(2+)-induced inactivation of HDL-associated paraoxonasel and oxidation of HDL; inactivation of paraoxonasel activity independent of HDL lipid oxidation. Nguyen SD; Sok DE Free Radic Res; 2004 Sep; 38(9):969-76. PubMed ID: 15621715 [TBL] [Abstract][Full Text] [Related]
12. Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia. Kostapanos MS; Milionis HJ; Lagos KG; Rizos CB; Tselepis AD; Elisaf MS Eur J Pharmacol; 2008 Aug; 590(1-3):327-32. PubMed ID: 18585701 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004. Ghandehari H; Kamal-Bahl S; Wong ND Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505 [TBL] [Abstract][Full Text] [Related]
14. Effect of ursodeoxycholic acid on copper induced oxidation of low density lipoprotein. Geetha A; Surendran R Pharmazie; 2005 Aug; 60(8):609-13. PubMed ID: 16124405 [TBL] [Abstract][Full Text] [Related]
15. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study. Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548 [TBL] [Abstract][Full Text] [Related]
16. Effects of oxidation on the structure and stability of human low-density lipoprotein. Jayaraman S; Gantz DL; Gursky O Biochemistry; 2007 May; 46(19):5790-7. PubMed ID: 17444660 [TBL] [Abstract][Full Text] [Related]
17. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia. Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694 [TBL] [Abstract][Full Text] [Related]
18. Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert's syndrome. Yesilova Z; Serdar M; Ercin CN; Gunay A; Kilciler G; Hasimi A; Uygun A; Kurt I; Erbil MK; Dagalp K J Gastroenterol Hepatol; 2008 Oct; 23(10):1556-60. PubMed ID: 18522683 [TBL] [Abstract][Full Text] [Related]
19. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology. Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059 [TBL] [Abstract][Full Text] [Related]
20. Modification of low-density lipoprotein by different radioiodination methods. Sobal G; Resch U; Sinzinger H Nucl Med Biol; 2004 Apr; 31(3):381-8. PubMed ID: 15028251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]